Cargando…
Correction to: Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients with Concomitant Heart Failure and either Reduced or Preserved Left Ventricular Ejection Fraction: Results from the Cryo AF Global Registry
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111503/ https://www.ncbi.nlm.nih.gov/pubmed/36752223 http://dx.doi.org/10.1161/JAHA.121.027597 |
Ejemplares similares
-
Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry
por: Rordorf, Roberto, et al.
Publicado: (2021) -
Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction
por: Chen, Chaofeng, et al.
Publicado: (2022) -
Cryoballoon ablation for paroxysmal atrial fibrillation in Japan: 2-year safety and efficacy results from the Cryo AF Global Registry
por: Kimura, Masaomi, et al.
Publicado: (2022) -
Validation of the SCALE-CryoAF risk model to predict very late return of atrial fibrillation after cryoballoon ablation
por: Nayak, Tanvi, et al.
Publicado: (2023) -
Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real‐world global setting: Results from the Cryo AF Global Registry
por: Chun, Kyoung Ryul Julian, et al.
Publicado: (2021)